Enigmatic entities: opsoclonus myoclonus ataxia syndrome linked to neuroblastoma-Reference-Cited by-同舟云学术

Enigmatic entities: opsoclonus myoclonus ataxia syndrome linked to neuroblastoma

Published:2018-01 Issue:1 Volume:2 Page:3-5
ISSN:2352-4642
Container-title:The Lancet Child & Adolescent Health
language:en
Short-container-title:The Lancet Child & Adolescent Health

Author:

Kushner Brian H,Khakoo Yasmin

Publisher

Elsevier BV

Subject

Developmental and Educational Psychology,Pediatrics, Perinatology, and Child Health

Reference10 articles.

1. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial;de Alarcon;Lancet Child & Adol Health,2017

2. Paraneoplastic syndromes in neuroblastoma;Posner;J Pediatr Hematol Oncol,2004

3. Update on pediatric opsoclonus myoclonus syndrome;Hero;Neuropediatrics,2013

4. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS);Krasenbrink;Neuropediatrics,2007

5. Neuroblastoma: developmental biology, cancer genomics and immunotherapy;Cheung;Nat Rev Cancer,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of Opsoclonus-Myoclonus Syndrome in Patients of the Largest Pediatric Hospital in Latin America;Pediatric Neurology;2024-05

2. Imaging Recommendations for Diagnosis, Staging, and Management of Pediatric Solid Tumors;Indian Journal of Medical and Paediatric Oncology;2023-02

3. Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach;Seminars in Diagnostic Pathology;2022-03

4. The glycosphingolipid GD2 as an effective but enigmatic target of passive immunotherapy in children with aggressive neuroblastoma (HR-NBL);Cancer Letters;2021-04

5. Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome;Journal of Pediatric Hematology/Oncology;2021-03-23